Source link : https://www.newshealth.biz/health-news/promising-new-data-support-glp-1s-for-dementia-prevention/
A new study supports the potential to repurpose glucagon-like peptide 1 (GLP-1) receptor agonists, used to treat type 2 diabetes and obesity, for dementia prevention. In the phase 2b ELAD clinical trial, adults with early-stage Alzheimer’s disease (AD) taking the GLP-1 receptor agonist liraglutide exhibited slower decline in memory and thinking and experienced less brain […]
Author : News Health
Publish date : 2024-07-31 12:14:35
Copyright for syndicated content belongs to the linked Source.
Categories